|
 Studies
 Merz - our research for your health. Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease.
Studies: learn more about the different forms of diseases, current research, drugs, treatment, therapies and care. Studies is a topic that anyone of us should think about, because when growing old, everyone could be affected. Inform yourself about Studies now! The care for elderly people and their diseases are a topic for our society, whose importance grows each day. That's why we at Merz take Studies very serious, so that we can offer you the best drug for each treatment and therapy you need. Studies and Merz means research for your health. High-quality products and information about Studies can be found on our website. Visit us online and learn everything about Studies from one of Germany's leading health care companies. Our contribution to Studies: read here what we can do for you. Further links: Axura: Information for professionals.>>
That's why we at Merz take Studies very serious, so that we can offer you the best drug for each treatment and therapy you need.
Memantine , Alzheimer's Treatment . Calcium enters into the cell, and through secondary processes, the signal is recognized. Such excitotoxicity ultimately leads to neuronal calcium overload and has been implicated in neurodegenerative disorders. Senile Dementia , Dementia Care . If you have questions regarding Memantine, Axura or Namenda, please contact the responsible department. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Alzheimer's Research , Alzheimer . Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. In the case of learning and memory processes, the transient synaptic release of glutamate causes more calcium to flow into the cell. At the same time, Memantine reduces caregiver time by more than 50 hours a month. A signal is produced which due to the lower noise can be recognized and processed which leads to a symptomatic improvement in dementia symptoms. Demenzkranke , Verwirrtheit Gedächtnisstörungen Short Term Memory Loss Symptoms Of Alzheimer's Disease . The intracellular calcium pool is reduced, and the noise lower. Alzheimer Erkrankung , Symptoms Of Alzheimer's Alzheimer's Disease Symptoms . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. In studies of memantine, doctors assessed tolerability as good or very good in 93 percent of patients. Alzheimer's Drug Dementia Symptoms , Hirnleistungsstörungen . Memantine has been developed as a monotherapeutic. This is clearly discernible behind the low background noise. Memantine is a NMDA receptor antagonist and protects the glutamatergic system from pathological activation. Clinically-relevant doses of memantine produce improvements in learning under conditions of tonic NMDA receptor activation in Alzheimer's disease. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. Demenz Krankheit Alzheimer Behandlung NMDA-Schutz Demenz Früherkennung , Mild Cognitive Impairment Altersdemenz . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Glutamatergic overstimulation results in neuronal damage, a phenomenon that has been termed excitotoxicity. Under physiological conditions, the NMDA receptor is blocked by magnesium ions, thereby protecting the neuron against glutamatergic excitotoxicity. Merz Pharmaceuticals, as a member of Merz Pharma, is an innovative and international healthcare company, specializing in the research, development and marketing of pharmaceuticals for the treatment of neurological and psychiatric diseases. The safety of the combination therapy was investigated in a postmarketing surveillance study. Alzheimer und Demenz , Glutamate Demenz Behandlung Demenz-Erkrankung . Glutamate is the principal neurotransmitter in the brain. Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Alzheimer's Disease Alzheimer Therapie , Symptoms Of Dementia . The safety of the combination therapy was investigated in a postmarketing surveillance study. NMDA-Antagonist Forgetfulness , Glutamat Alzheimer Früherkennung . vaskuläre Demenz , Lewy Body Dementia Demenz Therapie Vascular Dementia . During physiological learning and memory processes, high concentrations of synaptic glutamate are transiently released. Gedächtnis , Demenz . As memantine, in contrast to magnesium, blocks the NMDA receptor in the presence of sustained release of low glutamate concentrations, the influx of calcium is prevented (neuroprotection). This is clearly discernible behind the low background noise. Merz , Multi Infarct Dementia . Alzheimer's Dementia Axura , Vergesslichkeit Antidementiva Alzheimer's Caregiver . At the same time, Memantine reduces caregiver time by more than 50 hours a month. Stages Of Alzheimer's Disease , Akatinol Alzheimer's Support Hirnleistungsstörung NMDA-Protection . Due to its strong voltage-dependency, magnesium leaves the NMDA receptor. Alzheimer's , Demenzerkrankung Dementia . The intracellular calcium pool is reduced, and the noise lower. The starting point is the pathological release of glutamate, followed by elevated calcium concentrations. Memory Loss Pseudodemenz Alzheimer's Care , Dementia Treatment . Memantine is the first representative of a new class of Alzheimer drugs, a moderate affinity NMDA-receptor antagonist. Dementia And Alzheimer's Alzheimer Krankheit , Demenzkrank . The excitatory neurotransmitter glutamate plays an important part in the development of neurodegenerative diseases like dementia. Alzheimer's Symptoms , Mental Confusion . Memantine improves cognitive and psychomotor functioning, activities in daily living and the clinical global impression. Glutamate is the principal neurotransmitter in the brain. Dementia Medication Literatur , Erkennung Diagnose Studien . Memantine is well tolerated even in long-term therapy. Memantine is well tolerated even in long-term therapy. Medikamentkombinationen , Demenz Medikament . Therapy , Help . Diagnosis , Information Literature . Studies , Combination . Treatment Alzheimer's Therapie Demenz Alzheimer Medikament , Medication Alzheimer's .
 Studies
|
